Showing results (31-40 of 68) with videos related to
Sort By:
Pageof 7
The Journal of Pharmacology and Experimental Therapeutics|June 22, 2011
In vivo pharmacology and toxicology evaluation of polyethylene glycol-conjugated interferon beta-1aXiao Hu, Kenneth Olivier, Evelyne Polack, et al.The Journal of Biological Chemistry|November 23, 2006
Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signalingSurinder Kaur, Lakhvir Lal, Antonella Sassano, et al.Plos Neglected Tropical Diseases|January 12, 2016
A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola VirusStephen D S McCarthy, Beata Majchrzak-Kita, Trina Racine, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 17, 2014
Concomitant TLR/RLH signaling of radioresistant and radiosensitive cells is essential for protection against vesicular stomatitis virus infectionJulia Spanier, Stefan Lienenklaus, Jennifer Paijo, et al.Proceedings of the National Academy of Sciences of the United States of America|July 4, 2009
Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responsesSonali Joshi, Surinder Kaur, Amanda J Redig, et al.The Journal of Cell Biology|December 7, 2007
Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosisK G Suresh Kumar, Hervé Barriere, Christopher J Carbone, et al.The Journal of Investigative Dermatology|July 3, 2016
Therapeutic Elimination of the Type 1 Interferon Receptor for Treating Psoriatic Skin InflammationJun Gui, Michael Gober, Xiaoping Yang, et al.Proceedings of the National Academy of Sciences of the United States of America|November 7, 2012
Protein tyrosine phosphatase 1B is a key regulator of IFNAR1 endocytosis and a target for antiviral therapiesChristopher J Carbone, Hui Zheng, Sabyasachi Bhattacharya, et al.Journal of Clinical Pharmacology|June 18, 2011
A novel PEGylated interferon beta-1a for multiple sclerosis: safety, pharmacology, and biologyXiao Hu, Larisa Miller, Sandra Richman, et al.The Journal of Biological Chemistry|April 8, 2006
Activation of Tyk2 and Stat3 is required for the apoptotic actions of interferon-beta in primary pro-B cellsAna M Gamero, Ramesh Potla, Joanna Wegrzyn, et al.Pageof 7